NASDAQ: IFRX       Fireman B.V.
Last Price Today's Change   Day's Range   Trading Volume
3.87   -0.25 (6.07%)  3.82 - 4.15  92,768


Avg Volume (4 weeks):237,585
4 Weeks Range:3.82 - 5.39
4 Weeks Price Volatility (%):
52 Weeks Range:2.26 - 9.70
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

InflaRx NV is a clinical-stage biopharmaceutical company is focused on applying proprietary anti-C5a technology to discover and develop specific inhibitors of the complement activation factor known as C5a. The lead product candidate of the company is IFX-1, which is developed for the treatment of Hidradenitis Suppurativa, a rare and chronic debilitating systemic inflammatory skin disease. The company's proprietary anti-C5a technology is an inflammatory mediator involved in the progression of a variety of autoimmune and other inflammatory diseases. It is also developing IFX-1 for the treatment of AAV, a life-threatening autoimmune disease associated with powerful inflammatory flares that impair kidney function and lead to fatal organ dysfunction.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1646  4246  364  3140 

Top 10 Active Counters
 LK 1.38+1.38 
 BLRX 2.88+1.40 
 NIO 30.36-1.63 
 AAPL 109.155-6.165 
 OAS 0.155-0.014 
 SQQQ 25.345+1.985 
 TWTR 41.60-10.83 
 HTZ 1.780.00 
 GE 7.33-0.04 
 AMTD 39.97-0.85